| 000 | 04908cam a2200757Ia 4500 | ||
|---|---|---|---|
| 001 | ocn739118473 | ||
| 003 | OCoLC | ||
| 005 | 20171116135625.0 | ||
| 006 | m o d | ||
| 007 | cr cn||||||||| | ||
| 008 | 110706s2011 njua ob 001 0 eng d | ||
| 010 | _z 2010048282 | ||
| 020 |
_a9781118023648 _q(electronic bk.) |
||
| 020 |
_a1118023641 _q(electronic bk.) |
||
| 020 |
_a9781118023624 _q(electronic bk.) |
||
| 020 |
_a1118023625 _q(electronic bk.) |
||
| 020 |
_a9781118023631 _q(electronic bk.) |
||
| 020 |
_a1118023633 _q(electronic bk.) |
||
| 020 |
_z9780470256374 _q(Cloth) |
||
| 020 |
_z0470256370 _q(Cloth) |
||
| 024 | 8 | _a9786613175656 | |
| 029 | 1 |
_aAU@ _b000047774163 |
|
| 029 | 1 |
_aAU@ _b000053280043 |
|
| 029 | 1 |
_aDEBBG _bBV041911508 |
|
| 029 | 1 |
_aDEBSZ _b430992041 |
|
| 029 | 1 |
_aDKDLA _b820120-katalog:000571991 |
|
| 029 | 1 |
_aNLGGC _b337107459 |
|
| 029 | 1 |
_aDEBBG _bBV043393274 |
|
| 035 |
_a(OCoLC)739118473 _z(OCoLC)746598433 _z(OCoLC)747412436 _z(OCoLC)747545802 _z(OCoLC)769950588 _z(OCoLC)811493909 _z(OCoLC)816850645 _z(OCoLC)832584725 _z(OCoLC)961547718 _z(OCoLC)962639106 |
||
| 037 |
_a10.1002/9781118023648 _bWiley InterScience _nhttp://www3.interscience.wiley.com |
||
| 037 |
_aE7E4375E-C1F9-4065-A07F-245F67847567 _bOverDrive, Inc. _nhttp://www.overdrive.com |
||
| 040 |
_aDG1 _beng _epn _cDG1 _dCDX _dE7B _dN$T _dOCLCQ _dYDXCP _dOCLCQ _dMYG _dOCLCO _dOCLCQ _dOCLCO _dOCLCA _dOCLCF _dOCLCA _dOCLCQ _dNLGGC _dTEFOD _dDEBSZ _dMHW _dIDEBK _dUKDOC _dK6U _dDEBBG _dTEFOD _dOCLCQ _dEBLCP _dOCLCQ _dNKT _dOCLCQ _dD6H _dAZK |
||
| 049 | _aMAIN | ||
| 050 | 4 |
_aQR189 _b.D48 2011 |
|
| 060 | 4 | _aQW 805 | |
| 072 | 7 |
_aMED _x071000 _2bisacsh |
|
| 082 | 0 | 4 |
_a615/.372 _222 |
| 245 | 0 | 0 |
_aDevelopment of Vaccines : From Discovery to Clinical Testing / _cedited by Manmohan Singh, Indresh K. Srivasta. _h[electronic resource] |
| 260 |
_aHoboken, N.J. : _bJohn Wiley & Sons, _c©2011. |
||
| 300 |
_a1 online resource (xiii, 454 pages) : _billustrations (some color) |
||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_acomputer _bc _2rdamedia |
||
| 338 |
_aonline resource _bcr _2rdacarrier |
||
| 347 |
_adata file _2rda |
||
| 380 | _aBibliography | ||
| 504 | _aIncludes bibliographical references and index. | ||
| 505 | 0 | 0 |
_tMicrobial vaccines design : the reverse vaccinology approach / _rRoberto Rosini, Michele A. Barocchi, Rino Rappuoli -- _tDesign and development of recombinant vaccines with viral properties / _rGerd Lipowsky, Martin F. Bachmann -- _tTools for vaccine design : prediction and validation of highly immunogenic and conserved class II epitopes, and development of epitope-driven vaccines / _rAnne S. De Groot [and others] -- _tVirus like-particle vaccines advantages and challenges / _rTed M. Ross [and others] -- _tDesign platforms of nanocapsules for human therapeutics or vaccines / _rMasaaki Kawano [and others] -- _tDesigning immunogens for vaccine development in reference to HIV / _rAemro Kassa [and others]. |
| 505 | 8 | 0 |
_tExpression and purification of recombinant proteins for vaccine applications / _rCarlo Zambonelli, Deeann Martinez-Guzmann, and Indresh K. Srivastava -- _tDNA vaccines for infectious diesase / _rSamuel Stepenson, Manmohan Singh, Indresh K. Srivastava -- _tDeveloping stable cell lines for the production of vaccine antigens / _rXiaotian Zhong [and others] -- _tSpectroscopy of vaccines / _rC. Russell Middaugh, Sangeeta B. Joshi -- _tBiophysical characterization of protein antigens within vaccine formulations / _rPadima Malyala, Derek O'Hagan, Manmohan Singh -- _tStructural characteristics predict the stability of HIV / _rZohar Biron [and others] -- _tSelection of optimal adjuvants and product factors that affect vaccine immunogenicity / _rWei Wang, Manmohan Singh -- _tLyophilization and stabilization of vaccines / _rJames Chesko [and others] -- _tEffect of buffers and stabilizers on vaccine stability and efficacy / _rShireesh P. Apte, Sydney Ugwu -- _tSelection of final product containers / _rLuis Baez, Adrian Distler -- _tFrom the lab to the clinic : filing a phase I IND for an investigational vaccine / _rKenneth G. Surowitz. |
| 588 | 0 | _aPrint version record. | |
| 650 | 0 | _aVaccines. | |
| 650 | 0 | _aDrug development. | |
| 650 | 0 | _aDrug stability. | |
| 650 | 7 |
_aMEDICAL _xPharmacology. _2bisacsh |
|
| 650 | 7 |
_aDrug development. _2fast _0(OCoLC)fst00898670 |
|
| 650 | 7 |
_aDrug stability. _2fast _0(OCoLC)fst00898707 |
|
| 650 | 7 |
_aVaccines. _2fast _0(OCoLC)fst01163573 |
|
| 650 | 2 |
_aVaccines _xpharmacology. |
|
| 650 | 2 |
_aDrug Discovery _xmethods. |
|
| 650 | 2 | _aDrug Stability. | |
| 655 | 4 | _aElectronic books. | |
| 700 | 0 |
_aManmohan Singh, _d1964 November 8- |
|
| 700 | 1 | _aSrivasta, Indresh K. | |
| 776 | 0 | 8 |
_iPrint version: _tDevelopment of vaccines. _dHoboken, N.J. : John Wiley & Sons, ©2011 _z9780470256374 _w(DLC) 2010048282 _w(OCoLC)682072290 |
| 856 | 4 | 0 |
_uhttp://onlinelibrary.wiley.com/book/10.1002/9781118023648 _zWiley Online Library |
| 942 |
_2ddc _cBK |
||
| 999 |
_c205149 _d205149 |
||